By staining tumor sections for the CD31 marker, related to the tumor vasculature and to the angiogenesis-associated process, we found a trend for a decrease of vessel numbers in C51 FL Rnaset2 injected mice, suggesting a role for Rnaset2 in the inhibition of tumor angiogenesis (Figure 5C). This evidence concerns the gene RNASET2 and neoplasm.